{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:13:08Z","timestamp":1794535988865,"version":"4.9.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:p>Uterine endometrial stromal sarcomas (ESS) with <jats:italic toggle=\"yes\">YWHAE::NUTM2<\/jats:italic> gene fusions are typically morphologically high-grade tumors composed of atypical round cells, sometimes associated with a low-grade fibromyxoid component; they are currently included in the category of high-grade ESS (HGESS). We report 5 morphologically pure low-grade endometrial stromal tumors harboring <jats:italic toggle=\"yes\">YWHAE::NUTM2<\/jats:italic> fusions, including 1 endometrial stromal nodule (ESN) and 4 low-grade endometrial stromal sarcomas (LGESS), an association only occasionally reported previously. Patients ranged from 30 to 51 (mean=43) years and tumors from 4.5 to 7.5\u00a0cm (mean=5.7). All were stage I at diagnosis (confined to the uterus). Microscopically, the 4 LGESS showed extensive \u201ctongue-like\u201d invasion of the myometrium, and the ESN was entirely confined to the endometrium with no myometrial invasion. All tumors were composed entirely of morphologically uniform bland ovoid cells resembling proliferative endometrial stroma. A fibromyxoid component was seen in 1 LGESS and the ESN; in the LGESS, this was the sole component. Atypical round cells characteristic of <jats:italic toggle=\"yes\">YWHAE::NUTM2<\/jats:italic> HGESS were not identified. Mitotic count ranged from &lt;1 to 13 per 10 high-power fields (mean: 3). CD10 was positive in 2\/4 (focal), estrogen receptor in 5\/5 (focal=1; diffuse=4), progesterone receptor in 5\/5 (focal=1; diffuse=4) and cyclin D1 was diffusely positive in 3\/4. Follow-up was available in all 5 patients and ranged from 6 to 159 months (mean=72). Two patients with LGESS had recurrent disease at 15 and 155 months; 1 showed predominantly LGESS with rare round cells in the initial recurrence and pure HGESS in a subsequent recurrence, while the other patient\u2019s recurrent tumor was predominantly HGESS (90%) in a background of focal fibromyxoid LGESS (10%). Both patients rapidly progressed and died of disease within 5 months of high-grade recurrence. We show that rare cases of morphologically pure low-grade endometrial stromal tumors, some but not all with a fibromyxoid component, harbor <jats:italic toggle=\"yes\">YWHAE::NUTM2<\/jats:italic> fusions and may recur rapidly, with transformation to HGESS and aggressive behavior. Our findings suggest that at least a subset of <jats:italic toggle=\"yes\">YWHAE::NUTM2<\/jats:italic> HGESS evolves from LGESS. We suggest that cyclin D1 and CD10 staining should be performed in all LGESS. Diffuse staining for cyclin D1 and\/or negative or focal staining for CD10 should suggest the possibility of a <jats:italic toggle=\"yes\">YWHAE::NUTM2<\/jats:italic> fusion, and appropriate molecular testing should be undertaken. Since no single morphological or immunohistochemical parameter is entirely sensitive for fusion status, we also suggest that testing for a <jats:italic toggle=\"yes\">YWHAE::NUTM2<\/jats:italic> gene fusion should be considered in all cases of LGESS and, if a fusion is present, this should raise the possibility of subsequent high-grade transformation and aggressive behavior, even though such cases should still be categorized as LGESS. Although seemingly rare, ESN and LGESS with <jats:italic toggle=\"yes\">YWHAE::NUTM2<\/jats:italic> fusions may be under-recognized due to a lack of routine fusion testing.<\/jats:p>","DOI":"10.1097\/pas.0000000000002041","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T06:00:09Z","timestamp":1681106409000},"page":"717-724","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["Uterine Endometrial Stromal Tumors With Pure Low-Grade Morphology Harboring YWHAE::NUTM2 Fusions"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8097-2437","authenticated-orcid":false,"given":"Kyle M.","family":"Devins","sequence":"first","affiliation":[{"name":"Massachusetts General Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayoma D.","family":"Attygalle","sequence":"additional","affiliation":[{"name":"Royal Marsden Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Croce","sequence":"additional","affiliation":[{"name":"Institut Bergonie, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Vroobel","sequence":"additional","affiliation":[{"name":"Royal Marsden Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Oliva","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[{"name":"Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,10]]},"reference":[{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/00000478-199808000-00010","article-title":"Mixed endometrial stromal and smooth muscle tumors of the uterus: a clinicopathologic study of 15 cases","volume":"22","author":"Oliva","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/00000478-200209000-00004","article-title":"Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation","volume":"26","author":"Yilmaz","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00004347-199910000-00004","article-title":"Myxoid and fibrous endometrial stromal tumors of the uterus: a report of 10 cases","volume":"18","author":"Oliva","year":"1999","journal-title":"Int J Gynecol Pathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00004347-198402000-00008","article-title":"The clinical and histologic spectrum of endometrial stromal neoplasms: a report of 41 cases","volume":"3","author":"Fekete","year":"1984","journal-title":"Int J Gynecol Pathol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1073\/pnas.101132598","article-title":"Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors","volume":"98","author":"Koontz","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1073\/pnas.1115528109","article-title":"14-3-3 Fusion Oncogenes in High-Grade Endometrial Stromal Sarcoma","volume":"109","author":"Lee","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/PAS.0b013e31824a7b1a","article-title":"The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor","volume":"36","author":"Lee","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/gcc.22057","article-title":"Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22-translocation","volume":"52","author":"Pnagopoulos","year":"2013","journal-title":"Genes Chromosom Cancer"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PAS.0000000000000721","article-title":"Novel high-grade endometrial stromal sarcoma: a morphologic mimicker of myxoid leiomyosarcoma","volume":"41","author":"Hoang","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PAS.0000000000000993","article-title":"BCOR internal tandem duplication in high-grade uterine sarcomas","volume":"42","author":"Marin\u00f5-Enriquez","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/s41379-020-0535-y","article-title":"High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalities","volume":"33","author":"Zou","year":"2020","journal-title":"Mod Pathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ygyno.2017.03.021","article-title":"YWHAE-rearranged high-grade endometrial stromal sarcoma: two-center case series and resonse to chemotherapy","volume":"145","author":"Hemming","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/PGP.0000000000000286","article-title":"An unusual case of YWHAE-NUTM2A\/B endometrial stromal sarcoma with confinement to the endometrium and lack of high-grade morphology","volume":"36","author":"Attygalle","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/PGP.0000000000000451","article-title":"YWHAE rearrangement in a purely conventional low-grade endometrial stromal sarcoma that transformed over time to high-grade sarcoma: importance of molecular testing","volume":"37","author":"Aisagbonhi","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ijgo.12613","article-title":"Uterine sarcomas","volume":"143","author":"Mbatani","year":"2018","journal-title":"Int J Gynecol Obs"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/his.12406","article-title":"Evaluation of fluorescence in-situ hybridization in monomorphic endometrial stromal neoplasms and their histological mimics: a review of 49 cases","volume":"65","author":"Stewart","year":"2014","journal-title":"Histopathol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/gcc.22380","article-title":"Cytogenetic and molecular profile of endometrial stromal sarcoma","volume":"55","author":"Micci","year":"2016","journal-title":"Genes Chromosom Cancer"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/modpathol.2013.69","article-title":"YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations","volume":"26","author":"Croce","year":"2013","journal-title":"Mod Pathol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/sj.bjc.6604527","article-title":"Endometrial stromal sarcoma: a population-based analysis","volume":"99","author":"Chan","year":"2008","journal-title":"Br J Cancer"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1525-1578(10)60568-5","article-title":"JAZF1\/JJAZ1 gene fusion in endometrial stromal sarcomas","volume":"7","author":"Hrzenjak","year":"2005","journal-title":"J Mol Diagn"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/PAS.0b013e3182262743","article-title":"Frequency of known gene rearrangements in endometrial stromal tumors","volume":"35","author":"Chiang","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/modpathol.3880335","article-title":"Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases","volume":"14","author":"Chu","year":"2001","journal-title":"Mod Pathol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2559.2001.01215.x","article-title":"CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms","volume":"39","author":"McCluggage","year":"2001","journal-title":"Histopathol"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00000478-200204000-00001","article-title":"An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies","volume":"26","author":"Oliva","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1054\/bjoc.1999.1038","article-title":"Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas","volume":"82","author":"Reich","year":"2000","journal-title":"Br J Cancer"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/PAS.0b013e31825fa931","article-title":"Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement","volume":"36","author":"Lee","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/PGP.0000000000000424","article-title":"IFITM1 outperforms CD10 in differentiating low-grade endometrial stromal sarcomas from smooth muscle neoplasms of the uterus","volume":"37","author":"Busca","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1186\/s12885-021-08781-w","article-title":"IFITM1, CD10, SMA, and h-caldesmon as a helpful combination in differential diagnosis between endometrial stromal tumor and cellular leiomyoma","volume":"21","author":"Zhao","year":"2021","journal-title":"BMC Cancer"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:00:26Z","timestamp":1749416426000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002041"}},"subtitle":["Report of a Case Series Emphasizing Potential for High-Grade Transformation and Aggressive Behavior"],"short-title":[],"issued":{"date-parts":[[2023,4,10]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002041","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,10]]}}}